Home
About
Introduce
Chairman
Research technology
Culture
Memorabilia
Product
Puncture Consumables for Intramuscular Injection
Blood transfusion consumables
Dressings and other consumables
News
Company News
Party building style
Industry dynamics
Contact
Contact Information
Message feedback
Sales Network
The scenery is beautiful, the valley of the eyebrow is proud of the dawning warrior.
08
2018
/
NPC Vice Chairman Hua Jianmin Inspects Shuguang Jianshi Group
Warmly Congratulate Shuguang Jianshi Group on its 2012 Work Summary and Commendation Meeting Successfully Held
Warmly congratulate Wan Zhiyong, chairman of Shuguang Jianshi Group, on winning the honorary title of the second excellent builder of socialism with Chinese characteristics in Luohe City.
Warmly Congratulate Shuguang Jianshi Group on Winning Luohe Mayor Quality Award
Warmly Congratulate Henan Shuguang Jianshi Group 2012 Sincere Appreciation Friendship Conference Held
The FDA will issue a new medical device regulatory policy for medical device units or benefit.
The Shanghai Securities News reported that the reporter learned from the current State Food and Drug Administration yesterday that the drug administration will soon introduce two new medical device supervision policies, which will guide the registration of innovative medical device products and further simplify the re-registration requirements for medical devices. Industry insiders said that the introduction of relevant measures will help promote the merger and integration of the medical device industry and benefit the development of innovative medical device enterprises.
The future medical device consumer market will further expand
Of the medical instruments and equipment owned by 175000 medical and health institutions across the country, about 15% were products around the 1970 s and 60% were products before the mid-1980s. This also indicates that they need to be updated, and in this process, it will ensure the rapid growth of China's medical device market in the next 10 years or even longer.